Andrew Muncey

Andrew brings over 30 years’ experience in finance and management to Artios. He previously served as Co-founder and Chief Financial Officer of Acacia Pharma, and Chief Executive Officer of Amura Therapeutics. Andrew has been Chief Financial Officer or Finance Director of several healthcare companies, including MISSION Therapeutics, Bicycle Therapeutics, Kymab, Virttu Biologics and PhoreMost.

Andrew has raised significant amounts of equity and debt funding, including $500 million in private equity, and has completed many acquisitions, disposals and restructuring deals in the healthcare market. He has over 18 years’ corporate finance and capital markets experience from PricewaterhouseCoopers and UBS.